AIB1/SRC-3/NCOA3 function in estrogen receptor alpha positive breast cancer.

Saved in:

Bibliographic Details
Title:	AIB1/SRC-3/NCOA3 function in estrogen receptor alpha positive breast cancer.
Authors:	Kiliti AJ; Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, United States.; Department of Biochemistry, Molecular and Cellular Biology, Georgetown University, Washington, DC, United States., Sharif GM; Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, United States., Martin MB; Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, United States.; Department of Biochemistry, Molecular and Cellular Biology, Georgetown University, Washington, DC, United States., Wellstein A; Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, United States., Riegel AT; Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, United States.
Source:	Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2023 Aug 30; Vol. 14, pp. 1250218. Date of Electronic Publication: 2023 Aug 30 (Print Publication: 2023).
Publication Type:	Journal Article; Review; Research Support, N.I.H., Extramural
Journal Info:	Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101555782 Publication Model: eCollection Cited Medium: Print ISSN: 1664-2392 (Print) Linking ISSN: 16642392 NLM ISO Abbreviation: Front Endocrinol (Lausanne) Subsets: MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	1664-2392
DOI:	10.3389/fendo.2023.1250218